For patients requiring injectable therapy with cardiovascular or renal benefits, SGLT2 inhibitors (sodium-glucose co-transporter-2 inhibitors) such as empagliflozin, dapagliflozin, or canagliflozin offer an alternative mechanism of action with proven cardiovascular and renoprotective effects
While some patients choose to stay on maintenance doses of semaglutide for the rest of their lives, many are able to fully taper off after theyve hit their weight loss goalsand stay at that weight!so long as they follow a healthy diet and consistent exercise routine
See a healthcare provider immediately if you experience: An inability to eat Persistent or severe nausea that impacts your daily life Signs of dehydration (extreme thirst, dizziness, dry mouth, peeing less often) If your nausea is severe, consult with your prescribing physician or your GI team
Patients and health care professionals should understand that the agency does not review compounded versions of these drugs for safety, effectiveness, or quality," the FDA said in the safety warning